+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-Mullerian Hormone Test Market by Product, Component, Applications, End User - Global Forecast to 2030- Product Image
Anti-Mullerian Hormone Test Market by Product, Component, Applications, End User - Global Forecast to 2030- Product Image
Sale

Anti-Mullerian Hormone Test Market by Product, Component, Applications, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5292895
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Anti-Mullerian Hormone (AMH) Test Market is experiencing notable momentum as fertility management and women’s health continue to gain strategic importance for laboratories, clinics, and device manufacturers. Decision-makers are evaluating new diagnostic solutions as patient expectations and reimbursement frameworks rapidly evolve.

Market Snapshot: Anti-Mullerian Hormone Test Market Growth

The Anti-Mullerian Hormone Test Market expanded from USD 305.41 million in 2024 to USD 340.21 million in 2025. With a projected CAGR of 11.48%, the market is anticipated to reach USD 586.48 million by 2030. This upward trend reflects sustained investment in reproductive health as well as the influence of demographic and regulatory changes. The dynamic nature of diagnostic technology, coupled with accelerated demand for accessible and rapid results, positions AMH testing as a central pillar of women’s healthcare strategies worldwide.

Scope & Segmentation Overview

  • Product Segments: POC testing, self-check kits
  • Component Categories: Instruments, reagents and kits. Instruments cover benchtop devices and portable analyzers. Reagents and kits include customized assays and standard assays.
  • Key Applications: Ovarian reserve assessment, polycystic ovary syndrome diagnosis, premature ovarian failure prediction
  • End User Types: Diagnostic laboratories, fertility clinics, hospitals, research institutes
  • Regional Coverage:
    • Americas – United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa – United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific – China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Leading Companies Analyzed: Abbexa Limited, Ansh Labs LLC, Athenese-Dx, Bio-Rad Laboratories Inc., Bio-Techne Corporation, bioMérieux S.A., BioVendor - Laboratorni Medicina A.S., Chengdu VACURE Biotechnology Co. Ltd., CTK Biotech Inc., Cusabio Technology LLC, Danaher Corporation, Eagle Biosciences Inc., Elabscience Bionovation Inc., Epitope Diagnostics Inc., F. Hoffmann-La Roche Ltd., Fujirebio Europe N.V. by H.U. Group Holdings Inc., Goldsite Diagnostics Inc., Healthy Human Labs Limited (Vitall), Kamiya Biomedical Company, LifeSpan BioSciences Inc., London Gynaecology Limited, Meridian Bioscience Inc., Monobind Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tosoh Corporation, Vitrosens Biotechnology Co. Ltd.

Key Takeaways for Market Players

  • Technological innovation is driving a shift from traditional laboratory platforms toward compact, portable analyzers and consumer-empowering self-check kits, expanding the market beyond specialized clinics.
  • Strategic collaborations between manufacturers and regulatory agencies are streamlining product approval pathways, while investment in R&D alliances accelerates introduction of differentiated assay configurations.
  • Urbanization and rising maternal age are fueling demand for fertility diagnostics, with regional adoption patterns closely tied to reimbursement models and clinical infrastructure readiness.
  • End users expect high throughput and rapid turnaround in laboratory settings, while decentralized testing environments prioritize ease of use, mobility, and digital connectivity.
  • Companies leveraging integrated digital solutions, such as advanced analytics in instrument firmware and bundled biomarker panels, are establishing more advantageous competitive positions.

Tariff Impact on Supply Chain and Operations

Recent U.S. tariff measures have introduced new cost pressures for suppliers, particularly those importing reagents, customized assays, and diagnostic instruments. Many European and Asia-Pacific manufacturers are adapting strategies, including local production lines, diversified sourcing, and contract renegotiations, to address margin constraints. These adjustments have temporarily disrupted supply chains but are leading to longer-term shifts favoring nearshoring and collaborative procurement practices. Market participants investing in resilient, regionalized supply infrastructures are better positioned to mitigate ongoing volatility.

Methodology & Data Sources

The findings of this report are based on a multi-method approach, combining primary interviews with executives, clinical experts, and industry leaders, alongside extensive review of peer-reviewed literature, regulatory filings, and industry disclosures. Data triangulation and expert workshops ensured validated insights and actionable recommendations tailored to evolving market realities.

Why This Report Matters

  • Enables senior leaders to benchmark strategies against evolving market frameworks and identify areas for operational resilience and R&D investment.
  • Supports the selection of optimal product and technology portfolios in line with specific regional and segment growth trajectories.

Conclusion

This executive analysis equips decision-makers with the insight to navigate a changing diagnostic landscape shaped by technology, regulation, and consumer demand. Strategic planning based on these findings unlocks pathways for differentiation in the fast-evolving AMH testing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anti-Mullerian Hormone Test Market, by Product
8.1. Introduction
8.2. POC Testing
8.3. Self-check Kits
9. Anti-Mullerian Hormone Test Market, by Component
9.1. Introduction
9.2. Instruments
9.2.1. Benchtop Devices
9.2.2. Portable Analyzers
9.3. Reagents & Kits
9.3.1. Customized Assays
9.3.2. Standard Assays
10. Anti-Mullerian Hormone Test Market, by Applications
10.1. Introduction
10.2. Ovarian Reserve Assessment
10.3. Polycystic Ovary Syndrome Diagnosis
10.4. Premature Ovarian Failure Prediction
11. Anti-Mullerian Hormone Test Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Fertility Clinics
11.4. Hospitals
11.5. Research Institutes
12. Americas Anti-Mullerian Hormone Test Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anti-Mullerian Hormone Test Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anti-Mullerian Hormone Test Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbexa Limited
15.3.2. Ansh Labs LLC
15.3.3. Athenese-Dx
15.3.4. Bio-Rad Laboratories, Inc.
15.3.5. Bio-Techne Corporation
15.3.6. bioMérieux S.A.
15.3.7. BioVendor - Laboratorni Medicina A.S.
15.3.8. Chengdu VACURE Biotechnology Co., Ltd.
15.3.9. CTK Biotech, Inc.
15.3.10. Cusabio Technology LLC
15.3.11. Danaher Corporation
15.3.12. Eagle Biosciences, Inc.
15.3.13. Elabscience Bionovation Inc.
15.3.14. Epitope Diagnostics, Inc.
15.3.15. F. Hoffmann-La Roche Ltd.
15.3.16. Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
15.3.17. Goldsite Diagnostics Inc.
15.3.18. Healthy Human Labs Limited (Vitall)
15.3.19. Kamiya Biomedical Company
15.3.20. LifeSpan BioSciences, Inc.
15.3.21. London Gynaecology Limited
15.3.22. Meridian Bioscience, Inc.
15.3.23. Monobind Inc.
15.3.24. Siemens Healthineers AG
15.3.25. Thermo Fisher Scientific Inc.
15.3.26. Tosoh Corporation
15.3.27. Vitrosens Biotechnology Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANTI-MULLERIAN HORMONE TEST MARKET MULTI-CURRENCY
FIGURE 2. ANTI-MULLERIAN HORMONE TEST MARKET MULTI-LANGUAGE
FIGURE 3. ANTI-MULLERIAN HORMONE TEST MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTI-MULLERIAN HORMONE TEST MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY BENCHTOP DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PORTABLE ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY CUSTOMIZED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STANDARD ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OVARIAN RESERVE ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PREMATURE OVARIAN FAILURE PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 43. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 44. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 45. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 46. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 49. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 80. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 81. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 82. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 83. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 87. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 88. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 89. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 98. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 100. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 101. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 106. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 107. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 128. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 129. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 140. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 142. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 143. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 148. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 149. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 164. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 167. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 170. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 172. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 173. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 182. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 183. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 184. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 185. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 188. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 190. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 191. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 207. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 208. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 209. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 210. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 215. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 216. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 219. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 221. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 222. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 243. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 244. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 245. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2024
TABLE 278. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Anti-Mullerian Hormone Test market report include:
  • Abbexa Limited
  • Ansh Labs LLC
  • Athenese-Dx
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux S.A.
  • BioVendor – Laboratorni Medicina A.S.
  • Chengdu VACURE Biotechnology Co., Ltd.
  • CTK Biotech, Inc.
  • Cusabio Technology LLC
  • Danaher Corporation
  • Eagle Biosciences, Inc.
  • Elabscience Bionovation Inc.
  • Epitope Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
  • Goldsite Diagnostics Inc.
  • Healthy Human Labs Limited (Vitall)
  • Kamiya Biomedical Company
  • LifeSpan BioSciences, Inc.
  • London Gynaecology Limited
  • Meridian Bioscience, Inc.
  • Monobind Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Vitrosens Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 340.21 Million
Forecasted Market Value ( USD ) by 2030 $ 586.48 Million
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Endocrine Testing Market by Product Type, Technology, Test Type, End User, Sample Type - Global Forecast to 2030 - Product Image

Endocrine Testing Market by Product Type, Technology, Test Type, End User, Sample Type - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Endocrine Testing - Global Strategic Business Report - Product Image

Endocrine Testing - Global Strategic Business Report

  • Report
  • 168 Pages
  • Global
From
Radioimmunoassay Market Size, Share & Trends Analysis Report by Product (Analyzers, Reagents & Kits), Application (Research, Clinical Diagnostics), End Use (Hospitals, Laboratory), Region, with Growth Forecasts, 2025-2030 - Product Image

Radioimmunoassay Market Size, Share & Trends Analysis Report by Product (Analyzers, Reagents & Kits), Application (Research, Clinical Diagnostics), End Use (Hospitals, Laboratory), Region, with Growth Forecasts, 2025-2030

  • Report
  • 320 Pages
  • Global
From
Endocrine Testing Market Report 2025 - Product Image

Endocrine Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Fertility Testing Devices Market by Product Type, End User, Sales Channel, Technology - Global Forecast to 2030 - Product Image

Fertility Testing Devices Market by Product Type, End User, Sales Channel, Technology - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From

About the Anti Mullerian Hormone Test Market

The Anti Mullerian Hormone (AMH) Test is a diagnostic tool used to measure the amount of AMH in a person's blood. AMH is a hormone produced by the ovaries and is used to assess ovarian reserve, or the number of eggs a woman has left in her ovaries. The test is used to help diagnose infertility, polycystic ovary syndrome, and other conditions related to the reproductive system. It is also used to monitor the effectiveness of fertility treatments. The AMH Test market is a growing segment of the diagnostics industry. It is used by fertility clinics, obstetricians, and gynecologists to help diagnose and treat reproductive issues. The test is also used in research studies to better understand the reproductive system. Some companies in the AMH Test market include Beckman Coulter, Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.